4 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Understanding inflammation-associated tumorigenesis for the rational design of novel anti-cancer therapeutic strategies (INFLA-CARE)
Date du début: 1 janv. 2009, Date de fin: 30 juin 2013,
Epidemiological and experimental evidence supports a link between chronic inflammation and cancer and indicates a role for inflammatory cells in the initiation, progression and metastasis of malignancy. The objective of the collaborative integrated project INFLA-CARE is to structure a European collective of scientific and technological excellence in the field of ‘Inflammation & Cancer’ which will ...
Voir le projet
22
Participants partenaires
TERMINÉ
Building a cooperative strategy between Europe and Mediterranean Countries for upgrading tuberculosis research and control (EUMEDNETvsTB)
Date du début: 1 mars 2010, Date de fin: 28 févr. 2013,
Tuberculosis (TB) accounts amongst the most deadly infectious diseases worldwide. Despite the availability of a vaccine and effective drugs, Mycobacterium tuberculosis, the etiologic agent of TB, still defies the humanity. An alarming increase in drug resistance and emergence of outbreaks has made it urgent the need for increased surveillance and control. With its structured global geographical di ...
Voir le projet
7
Participants partenaires
TERMINÉ
A new platform for fast molecular detection of MDR and XDR resistant strains of M. tuberculosis and of drug resistant malaria (TM-REST)
Date du début: 1 janv. 2008, Date de fin: 30 juin 2011,
"Recent developments in molecular tools combined with updated epidemiological data provide novel challenges to the development of modern molecular diagnostics. The increasing threat of infections due to Mycobacterium tuberculosis, including multidrug-resistant (MDR) and extensively drug-resistant (XDR) infections poses important questions that call for development of integrated tools for rapid dia ...
Voir le projet
9
Participants partenaires
TERMINÉ
European initiative to improve knowledge, treatment and survival of haemophagocytic syndromes in children (CureHLH)
Date du début: 1 juin 2008, Date de fin: 31 mai 2011,
Haemophagocytic lymphohistiocytosis (HLH) is a rare and life-threatening inherited immune disorder of early childhood characterised by an uncontrolled immune response. Three disease causing genes have been identified in about half of the patients. Diagnosis is difficult, pathophysiology poorly understood, and treatment unsatisfactory with about 40% of the children dying from treatment failure or t ...
Voir le projet